Copeptin as a Prognostic Marker in Acute Chest Pain and Suspected Acute Coronary Syndrome.

ABSTRACT:

Background

In patients admitted with chest pain and suspected acute coronary syndrome (ACS), it is crucial to early identify those who are at higher risk of adverse events. The study aim was to assess the predictive value of copeptin in patients admitted to the emergency department with chest pain and nonconclusive ECG.

Methods

Consecutive patients suspected for an ACS were enrolled prospectively. Copeptin and high-sensitive troponin T (hs-TnT) were measured at admission. Patients were followed up at six and 12 months for the occurrence of death and major adverse cardiac and cerebrovascular events (MACCE).

Results

Among 154 patients, 11 patients died and 26 experienced MACCE. Mortality was higher in copeptin-positive than copeptin-negative patients with no difference

SUBMITTER: Morawiec B 

PROVIDER: S-EPMC5829365 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature